| Perspectives and challenges in advancing research into craniofacial anomalies |
|
|
|
|
|
|
|
|
|
| Genomic approaches for studying craniofacial disorders |
|
|
|
|
|
|
|
|
|
| Clinical care in craniofacial microsomia: A review of current management recommendations and opportunities to advance research |
|
|
|
|
|
|
|
|
|
| Genotype and clinical care correlations in craniosynostosis: Findings from a cohort of 630 Australian and New Zealand patients |
|
|
|
|
|
|
|
|
|
| Developmental and genetic perspectives on Pierre Robin sequence |
|
|
|
|
|
|
|
|
|
| Understanding the basis of auriculocondylar syndrome: Insights from human, mouse and zebrafish genetic studies |
|
|
|
|
|
|
|
|
|
| Developmental disorders of the dentition: An update |
|
|
|
|
|
|
|
|
|
| Facial dysostoses: Etiology, pathogenesis and management |
|
|
|
|
|
|
|
|
|
| The ontology of craniofacial development and malformation for translational craniofacial research |
|
|
|
|
|
|
|
|
|
| Modeling anterior development in mice: Diet as modulator of risk for neural tube defects |
|
|
|
|
|
|
|
|
|
| Genetics of cleft lip and cleft palate |
|
|
|
|
|
|
✓ |
✓ |
ethnic diversity |
| Implications of genetic testing in noncompaction/hypertrabeculation |
|
|
|
|
|
|
|
|
|
| Barth syndrome |
|
|
|
|
|
|
|
|
|
| Disorders of left ventricular trabeculation/compaction or right ventricular wall formation |
|
|
|
|
|
|
|
|
|
| Molecular mechanism of ventricular trabeculation/compaction and the pathogenesis of the left ventricular noncompaction cardiomyopathy (LVNC) |
|
|
|
|
|
|
|
|
|
| Arrhythmogenic right ventricular cardiomyopathy/Dysplasia (ARVC/D) |
|
|
|
|
|
|
|
|
|
| Ebstein anomaly associated with left ventricular noncompaction: An autosomal dominant condition that can be caused by mutations in MYH7 |
|
|
|
|
|
|
|
|
|
| Embryonic cardiac chamber maturation: Trabeculation, conduction, and cardiomyocyte proliferation |
|
|
|
|
|
|
|
|
|
| Noncompaction in the fetus and neonate: An autopsy study |
|
|
|
|
|
|
|
|
|
| Perlman Syndrome: Overgrowth, Wilms Tumor Predisposition and <i>DIS3L2</i> |
|
|
|
|
|
|
|
|
|
| When Overgrowth Bumps Into Cancer: The PTEN‐Opathies |
|
|
|
|
|
|
|
|
|
| Endocrine Control of Growth |
|
|
|
|
|
|
|
|
|
| Phenotypic Spectrum of Simpson–<scp>G</scp>olabi–<scp>B</scp>ehmel Syndrome in a Series of 42 Cases With a Mutation in <scp><i>GPC</i></scp><i>3</i> and Review of the Literature |
|
|
|
|
|
|
|
|
|
| Molecular Mechanisms of Childhood Overgrowth |
|
|
|
|
|
|
|
|
|
| The <i>NSD</i><i>1</i> and <i>EZH</i><i>2</i> Overgrowth Genes, Similarities and Differences |
|
|
|
|
|
|
|
|
|
| Megalencephaly Syndromes and Activating Mutations in the PI3K‐AKT Pathway: MPPH and MCAP |
|
|
|
|
|
|
|
|
|
| Molecular Findings in Beckwith–Wiedemann Syndrome |
|
|
|
|
|
|
|
|
|
| Endocrine Control of Growth |
|
|
|
|
|
|
|
|
|
| Perlman Syndrome: Overgrowth, Wilms Tumor Predisposition and<i>DIS3L2</i> |
|
|
|
|
|
|
|
|
|
| When Overgrowth Bumps Into Cancer: The PTEN-Opathies |
|
|
|
|
|
|
|
|
|
| 47,XXY Klinefelter syndrome: Clinical characteristics and age‐specific recommendations for medical management |
|
|
|
|
|
|
|
|
|
| Immunodeficiency in patients with 49,XXXXY chromosomal variation |
|
|
|
|
|
|
|
|
|
| Introduction: Past, present, and future care of individuals with XXY |
|
|
|
|
|
|
|
|
|
| Is it all the X: Familial learning dysfunction and the impact of behavioral aspects of the phenotypic presentation of XXY? |
|
|
|
|
|
|
|
|
|
| Musculoskeletal anomalies in a large cohort of boys with 49, XXXXY |
|
|
|
|
|
|
|
|
|
| Prenatal diagnosis and 47,XXY |
|
|
|
|
|
|
|
|
|
| Endocrinological issues and hormonal manipulation in children and men with Klinefelter syndrome |
|
|
|
|
|
|
|
|
|
| Sexual differentiation of the brain in man and animals: Of relevance to Klinefelter syndrome? |
|
|
|
|
|
|
|
|
|
| Neurocognitive variance and neurological underpinnings of the X and Y chromosomal variations |
|
|
|
|
|
|
|
|
|